- Category
- Medium (2024-25)
- Udyam number
- UDYAM-KR-03-0000216

About Stericon Pharma Private Limited
Data last updated:
Stericon Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Nirma Chemical Works Private Limited. It operates in the lifestyle products and accessories manufacturing segment of the home and lifestyle products sector. It was incorporated on 10 July 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U33201KA1990PTC011056. Its GSTIN is 29AAACV6622N1ZU (Karnataka). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹4.75 Cr and a paid-up capital of ₹4.37 Cr. It was formerly known as Vista Optics (I) Pvt Ltd. It is led by directors including Amar Narendrabhai Shah and Chinmay Rajesh Vasa.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.9R Sub Layout Of Plot No.9 1st Phase Bommasandra Industrial Area, Bangalore, Karnataka, India – 560099.
As per the financials filed for FY 2025, the company reported a revenue of ₹169.15 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹48.24 Cr (net margin 28.5%) and EBITDA of ₹67.94 Cr (EBITDA margin 40.2%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 15% over five years.
The company has about 222 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Stericon. As per MCA filings, the company has satisfied charges of ₹16.96 Cr on record. Court records list 3 cases involving the company, including 3 filed against it. The company has 7 deals on record (4 funding rounds, 3 secondary share transfers), with disclosed funding of ₹53.44 Cr; the latest was in March 2023. Its 5 peer companies in the Consumer Products industry (Formulations, Lifestyle and Accessories Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 2 smaller; the largest is BDR Lifesciences Private Limited with revenue of ₹176.87 Cr.
Stericon Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0000216). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website stericon.net.
Company details
Recognitions & Rankings of Stericon Pharma
Contact details
Stericon Pharma Private Limited's registered office is in Bangalore, Karnataka. Its website is stericon.net. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo.9R Sub Layout Of Plot No.9 1st Phase Bommasandra Industrial Area, Bangalore, Karnataka, India – 560099
- IndustryHome & Lifestyle, Lifestyle Products & Accessories Manufacturing
To see the full contact details of Stericon Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Stericon Pharma operates one associated brand: Stericon. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Private label contact lens cleaning solutions are manufactured by Stericon. | stericon.net |
Business activity
The main business activities of Stericon Pharma are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Stericon Pharma Private Limited, buy the company report.
Financials of Stericon Pharma Private Limited
FY 2025 filings availableStericon Pharma Private Limited reported revenue of ₹169.15 Cr (up 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 21% growth in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹67.94 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹48.24 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 40.2% | ||||
| Net Profit Margin | 28.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Stericon Pharma Private Limited, buy the company report.
Board of directors of Stericon Pharma Private Limited
Stericon Pharma has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amar Narendrabhai Shah Also directs: Ocular Enterprise Private Limited, Aculife Healthcare Private Limited, Nirma Industries Private Limited and 1 more | Director | 28 Mar 2023 | 3 Years 7 Months | Current |
| Chinmay Rajesh Vasa | Director | 28 Mar 2023 | 3 Years 7 Months | Current |
| Ajay Bhushanlal Khushu | Director | 03 Apr 2024 | 2 Years 7 Months | Current |
Peer comparison
Stericon Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Consumer Products industry (Formulations, Lifestyle and Accessories Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| BDR Lifesciences Private Limited | ₹176.87 Cr (FY 2025) | -5.0% | Vadodara, Gujarat, India | |||
| Bakson Drugs and Pharmaceuticals Private Limited | ₹172.81 Cr (FY 2025) | 15.0% | New Delhi, Delhi, India | |||
| Shree Krishnakeshav Laboratories Limited | ₹170.52 Cr (FY 2025) | 13.0% | Ahmedabad, Gujarat, India | |||
| Stericon Pharma Private Limitedthis company | ₹169.15 Cr (FY 2025) | ₹48.24 Cr | 28.5% | 21.0% | 222 | Bangalore, Karnataka, India |
| Eurolife Healthcare Private Limited | ₹168.9 Cr (FY 2020) | -20.0% | Thane, Maharashtra, India | |||
| Group Pharmaceuticals Limited | ₹168.31 Cr (FY 2025) | 10.0% | Thane, Maharashtra, India |
To see the full peer comparison of Stericon Pharma Private Limited, buy the company report.
Auditor
Stericon Pharma Private Limited is audited by Price Waterhouse Chartered Accountants LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Price Waterhouse Chartered Accountants LLP | FY 2023 | 012754N/N500016 |
Shareholding
The shareholding of Stericon Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Stericon Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Mar 2020 | 100332903 | Hdfc Bank Limited | ₹10 Cr | Satisfied | |
| 16 Dec 2016 | 100110804 | Others | ₹46 Lakh | Satisfied | |
| 03 Oct 2016 | 100110801 | Hdfc Bank Limited | ₹49 Lakh | Satisfied | |
| 06 Mar 2008 | 10143647 | Others | ₹5.46 Cr | Satisfied | |
| 10 Sep 2004 | 80055510 | State Bank of India | ₹13.5 Lakh | Satisfied |
To see the full charge records of Stericon Pharma Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Stericon Pharma Private Limited has 7 deals on record (4 funding rounds, 3 secondary share transfers), with disclosed funding of ₹53.44 Cr; the latest was in March 2023.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: Nirma Chemical Works Private Limited Seller: InvAscent, 2 individuals |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Silklens Private Limited , Crystal Vision Private Limited , an individual |
| Feb 2013 | Funding round | ₹25 Lakh | Investors: 2 individuals |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2008 | Funding round | ₹38.8 Lakh | Investors: Silklens Private Limited , Crystal Vision Private Limited |
To see the full deal history of Stericon Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Stericon Pharma Private Limited has 3 court cases on record: 3 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 0 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (0104-Labour Matters : Matters relating to wages, bonus, ad-hoc, casual daily wages & their regularisation) | Filed against the company by Group Pharmaceuticals Ltd. Managing Directors 521/A, 2Nd Block, 2Nd Main 2Nd Stage Rajaji Nagar Bengaluru-560055 ,Bangalore , Karnataka and 10 others | Disposed |
| High Court of Karnataka | Appeal | Filed against the company | Disposed |
| High Court of Karnataka | Writ petition | Filed against the company | Disposed |
To see the full case history of Stericon Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Stericon Pharma Private Limited was last rated by Crisil on 19 Nov 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 19 Nov 2020 |
To see the full credit ratings and regulatory alerts of Stericon Pharma Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Stericon Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Stericon Pharma Private Limited has a workforce of 222 employees on its EPFO records as of Mar 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2025-26 | 222 |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Stericon Pharma Private Limited, buy the company report.
GST
Stericon Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAACV6622N1ZU | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Stericon Pharma Private Limited, buy the company report.
Recent activity
Stericon Pharma Private Limited has 10 board changes on record since 2009: 3 appointments and 7 cessations. The latest: Ajay Bhushanlal Khushu ceased to be Additional Director on 08 Aug 2024.
16 earlier events are in the company report.
Frequently asked questions
Stericon Pharma is an active private limited company based in Bangalore, Karnataka, India. The company works in lifestyle products and accessories manufacturing, within the home and lifestyle industry. It was incorporated on 10 July 1990 (36+ years old) and is registered under CIN U33201KA1990PTC011056.
Stericon Pharma has 3 current directors:
- Amar Narendrabhai Shah - Director
- Chinmay Rajesh Vasa - Director
- Ajay Bhushanlal Khushu - Director
The latest financial statements of Stericon Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Stericon Pharma is 29AAACV6622N1ZU, registered in Karnataka. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Stericon Pharma is U33201KA1990PTC011056. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stericon Pharma has 3 court cases on record: 3 filed against it. Most are in the high courts.
Stericon Pharma was incorporated on 10 July 1990, making it 36+ years old. It is registered with the Registrar of Companies, Bangalore.
Stericon Pharma has 7 deals on record (4 funding rounds, 3 secondary share transfers), with disclosed funding of ₹53.44 Cr; the latest was in March 2023.
The peers of Stericon Pharma by revenue are BDR Lifesciences Private Limited, Bakson Drugs and Pharmaceuticals Private Limited, Shree Krishnakeshav Laboratories Limited, Eurolife Healthcare Private Limited, Group Pharmaceuticals Limited, all in the Consumer Products industry (Formulations, Lifestyle and Accessories Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ajay Bhushanlal Khushu ceased to be Additional Director on 08 Aug 2024. Ajay Bhushanlal Khushu was appointed as Director on 03 Apr 2024. Amar Narendrabhai Shah ceased to be Additional Director on 29 Mar 2023. Stericon Pharma has 10 board changes on record in total.
Yes, Stericon Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-KR-03-0000216).

